Innate Pharma S.A. (IPHA)
1.97
0.03 (1.55%)
At close: Apr 17, 2025, 3:51 PM
13F Institute Ownership
Total Institutes of 9 in Innate Pharma S.A. expanded their positions with an increase of 1 investors compared to the previous quarter. A reduction of 100.08K shares, as total invested capital declined by $290.23K with ownership percentage dropping from 0.30% to 0.17%.
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Exchange Traded Concepts, LLC | 0.10% | 77.35K | +0.00% | 143.1K | < 0.01% |
| Morgan Stanley | 0.05% | 43.52K | +0.00% | 80.08K | < 0.01% |
| Citadel Advisors LLC | 0.01% | 11.85K | -44.27% | 21.93K | < 0.01% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.